Marco Corda

667 total citations
30 papers, 215 citations indexed

About

Marco Corda is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Marco Corda has authored 30 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Marco Corda's work include Cardiac pacing and defibrillation studies (4 papers), Cardiac Imaging and Diagnostics (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Marco Corda is often cited by papers focused on Cardiac pacing and defibrillation studies (4 papers), Cardiac Imaging and Diagnostics (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Marco Corda collaborates with scholars based in Italy, United States and Canada. Marco Corda's co-authors include Maurizio Porcu, Gildo Matta, Pierluigi Stefàno, Iacopo Olivotto, Anna Arretini, Mattia Targetti, Alessandra Rossi, Alessandra Fornaro, Gabriele Castelli and Francesca Girolami and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Transplantation.

In The Last Decade

Marco Corda

24 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Corda Italy 7 146 62 51 22 22 30 215
Kentaro Honda Japan 9 104 0.7× 168 2.7× 62 1.2× 9 0.4× 27 1.2× 44 237
Antoine AbdelMassih Egypt 10 81 0.6× 38 0.6× 58 1.1× 29 1.3× 61 2.8× 43 197
Felipe Martinez United States 8 53 0.4× 56 0.9× 105 2.1× 23 1.0× 46 2.1× 21 216
Małgorzata Peregud‐Pogorzelska Poland 6 74 0.5× 35 0.6× 28 0.5× 10 0.5× 12 0.5× 45 144
Virginie Barbay France 9 86 0.6× 48 0.8× 16 0.3× 25 1.1× 17 0.8× 22 235
Christopher J. Mullin United States 10 94 0.6× 52 0.8× 158 3.1× 16 0.7× 33 1.5× 26 244
Carmelo De Gori Italy 10 122 0.8× 43 0.7× 51 1.0× 5 0.2× 35 1.6× 23 287
Jagan Rao United Kingdom 10 24 0.2× 181 2.9× 110 2.2× 13 0.6× 25 1.1× 28 265
David J. Bowden United Kingdom 11 134 0.9× 74 1.2× 202 4.0× 11 0.5× 59 2.7× 20 306
Tamer Sayın Türkiye 9 193 1.3× 130 2.1× 118 2.3× 4 0.2× 21 1.0× 21 302

Countries citing papers authored by Marco Corda

Since Specialization
Citations

This map shows the geographic impact of Marco Corda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Corda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Corda more than expected).

Fields of papers citing papers by Marco Corda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Corda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Corda. The network helps show where Marco Corda may publish in the future.

Co-authorship network of co-authors of Marco Corda

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Corda. A scholar is included among the top collaborators of Marco Corda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Corda. Marco Corda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luca, Leonardo De, Claudio Bilato, Alessandro Navazio, et al.. (2025). ANMCO statement: semaglutide in the cardio-nephro-metabolic continuum. European Heart Journal Supplements. 27(Supplement_5). v247–v255. 2 indexed citations
2.
Luca, Leonardo De, Francesco Pugliese, Alessandro Navazio, et al.. (2024). Documento di consenso ANMCO/SIMEU sull’impiego degli agenti di reversione delle terapie antitrombotiche nei pazienti con sanguinamento in atto o ad alto rischio di eventi emorragici. Giornale italiano di cardiologia. 25(1). 60–69. 1 indexed citations
3.
Fusco, Stefania Angela Di, Edoardo Mocini, Mauro Gori, et al.. (2024). Italian Association of Hospital Cardiologists position paper—obesity in adults: a clinical primer. European Heart Journal Supplements. 26(Supplement_2). ii221–ii235. 2 indexed citations
4.
Luca, Leonardo De, Francesco Pugliese, Alessandro Navazio, et al.. (2024). ANMCO/SIMEU consensus document on the use of reversal agents for antithrombotic therapies in patients with ongoing bleeding or at high risk of haemorrhagic events. European Heart Journal Supplements. 26(Supplement_2). ii211–ii220. 1 indexed citations
5.
Casula, Matteo, Riccardo Cau, Matteo Castrichini, et al.. (2024). The Detection Rate of Late Gadolinium Enhancement in Takotsubo Syndrome: A Systematic Review and Meta-Analysis. The American Journal of Cardiology. 238. 32–39. 1 indexed citations
6.
Luca, Leonardo De, Carmine Riccio, Alessandro Navazio, et al.. (2023). Position paper ANMCO: Gestione dell’ipercolesterolemia nei pazienti con sindrome coronarica acuta. Giornale italiano di cardiologia. 24(3). 229–240. 1 indexed citations
7.
Cau, Milena, et al.. (2023). Danon disease in a Sardinian family: different aspects of the same mutation—a case report. European Heart Journal - Case Reports. 7(5). ytad237–ytad237.
8.
Luca, Leonardo De, Carmine Riccio, Alessandro Navazio, et al.. (2023). ANMCO position paper on the management of hypercholesterolaemia in patients with acute coronary syndrome. European Heart Journal Supplements. 25(Supplement_D). D312–D322. 2 indexed citations
9.
Casolo, Giancarlo, Michele Massimo Gulizia, Daniela Aschieri, et al.. (2023). Position paper ANMCO: Guida all’uso appropriato del defibrillatore indossabile nella pratica clinica per i pazienti ad elevato rischio transitorio di morte improvvisa. Giornale italiano di cardiologia. 24(5). 394–411. 1 indexed citations
10.
Casolo, Giancarlo, Michele Massimo Gulizia, Daniela Aschieri, et al.. (2023). ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death. European Heart Journal Supplements. 25(Supplement_D). D294–D311. 6 indexed citations
11.
Atzeni, Fabiola, et al.. (2023). Diagnosis and management of cardiovascular risk in rheumatoid arthritis: main challenges and research agenda. Expert Review of Clinical Immunology. 19(3). 279–292. 2 indexed citations
14.
Atzeni, Fabiola, et al.. (2020). Cardiovascular Consequences of Autoimmune Rheumatic Diseases. Current Vascular Pharmacology. 18(6). 566–579. 11 indexed citations
15.
Atzeni, Fabiola, Marco Corda, L. Gianturco, et al.. (2018). Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. Frontiers in Medicine. 5. 26–26. 7 indexed citations
16.
Badagliacca, Roberto, Amresh Raina, Stefano Ghio, et al.. (2017). Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 37(3). 365–375. 40 indexed citations
17.
Potena, Luciano, Carlo Pellegrini, Francesco Grigioni, et al.. (2017). Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients. Transplantation. 102(3). 493–501. 19 indexed citations
18.
Corda, Marco, Matthew Gavino Donadu, Donatella Usai, et al.. (2017). Total hip prosthesis complication, periprosthetic infection with external fistulizing due to Enterobacter cloacae complex multiple drugs resistance: A clinical case report. International Journal of Surgery Case Reports. 36. 90–93. 2 indexed citations
19.
Porcu, Maurizio, Stefano Salis, Marco Corda, et al.. (2006). Effects of Combined Deferiprone and Desferrioxamine Iron Chelating Therapy in β-Thalassemia Major End-Stage Heart Failure. European Journal of Heart Failure. 9(3). 320–322. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026